Countries that have legalised some aspects of sex work have fewer sex workers living with HIV than countries that criminalise all aspects of sex work, according to an ecological analysis of 27 European countries published online ahead of print in The Lancet HIV. The association remained ...

Researchers recently published their findings on a combination therapy for use in patients with hepatitis C (HCV) genotype 4 in PLoS One. According to the Belgian researchers, sofosbuvir in combination with simeprevir with or without ribarivirn was found to be safe and effective. According to the ...

Although the use of needles to inject illegal drugs is a known risk factor in the transmission of HIV (more than 180,000 injectable drug users with HIV have died since the HIV epidemic began), less attention has been paid to general patterns of drug use ...

PARIS, February 02, 2017 – ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral diseases, announced today that the previously disclosed results of its two Phase I trials with ABX464 in healthy volunteers have now been ...

U.S. FDA grants priority review to AbbVie for its investigational regimen of glecaprevir/pibrentasvir (G/P) for the treatment of chronic hepatitis C in all major genotypes (GT1-6) – If approved, G/P will provide an eight week, once-daily, ribavirin-free cure* for HCV patients without cirrhosis across all major ...

In first-ever study, Case School of Medicine researchers to pair monoclonal antibody with body’s own killer-cell stimulator Newswise — A Case Western Reserve University School of Medicine researcher has received a $2.5 million grant from Gilead Sciences, a California-based biopharmaceutical company, to see if two so-far ...

A research team at UNMC has used a process they call LASER ART (long-acting slow effective release antiretroviral therapy) to discover an unexpected pathway to open cell storage areas for antiviral drugs. The discovery could revolutionize current treatments for HIV/AIDS by extending the actions of ...

The Global Review Panel on the Future of the UNAIDS Joint Programme Model has launched a virtual consultation that will run until 10 February. The panel is seeking input on how the Joint Programme can be refined and reinforced to better support countries to end ...